Résultats de la recherche - Pedro Rodrigues
-
1
-
2
Zygomatic-palpebral flap: an optional technique for lower eyelid reconstruction
Publié 2019-03-01Accéder au texte intégralIntroduction: Lower eyelid reconstruction represents a unique challenge to plastic surgeons, since it involves a facial region of aesthetic and functional importance. The objective is to present an optional technique for the reconstruction of lower eyelid defects using zygomatic-palpebral skin flap....
Article -
3
Scale-Up Cultivation of the Dinoflagellate <i>Durusdinium glynnii</i> Under Varying Inoculum Percentages: Effects on Growth Performance and Fatty Acid Profile
Publié 2025-06-01Accéder au texte intégralMicroalgae are photosynthetic organisms with rapid growth and high biochemical diversity, capable of thriving in a variety of environments. Among them, dinoflagellates, particularly symbiotic species like <i>Durusdinium glynnii</i>, have gained attention due to their potential for biotec...
Article -
4
Digital organization of Plastic Surgery Service
Publié 2019-12-01Accéder au texte intégralThe attention and enthusiasm of doctors in the pre- and postoperative period is of extreme importance in maintaining good doctor/patient relationships. An adequate organization and documentary record contributes to achieving a good relationship and ensures an important legal tool for physicians. Wit...
Article -
5
Real-life management of nonobstructive esophageal dysphagia: analysis of a prospective multicentric Portuguese cohort
Publié 2025-06-01Accéder au texte intégralBackground: Nonobstructive esophageal dysphagia (NOD) is a common benign condition that significantly impacts quality of life. Management requires a motility-focused approach and consideration for concomitant comorbidities such as gastroesophageal reflux, visceral hypersensitivity, and psychological...
Article -
6
SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper
Publié 2025-08-01Accéder au texte intégralAbstract Background Sodium glucose co‐transporter 2 inhibitors (SGLT2i) and mineralocorticoid receptor antagonists (MRA) reduce heart failure (HF) events in patients with heart failure and mildly reduced or preserved ejection fraction (HFmr/pEF). The randomized comparison of SGLT2i/MRA combination v...
Article